• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M
$XRP: Cryptocurrency Prospects in 2025

$XRP: Cryptocurrency Prospects in 2025

user avatar

by Giorgi Kostiuk

10 months ago


In 2025, $XRP becomes a focal point due to the resolution of the SEC vs Ripple case and the planning of an ETF launch.

SEC vs Ripple Case Resolved

The lawsuit between the SEC and Ripple, dating back to 2020, finally reached a conclusion. The SEC had accused Ripple of selling unregistered securities ($XRP) during their ICO in 2013. However, in July 2023, a U.S. court ruled that $XRP is not a security when sold on public exchanges. As a result, the SEC dropped charges against Ripple's founders, Garlinghouse and Larsen, although they continued seeking penalties. The appeal deadline is January 15, 2025, coinciding with SEC Chair Gary Gensler's departure.

$XRP ETF Plans

Four firms, including 21Shares and Bitwise, have applied for an $XRP-based ETF. According to Polymarket predictions, $XRP has a 71% chance of approval this year. With changes in SEC leadership, an approval could boost $XRP's price by late this year.

$XRP Strategic Reserve

In a recent interview, Ripple's CEO Brad Garlinghouse mentioned the concept of a strategic reserve in cryptocurrencies, including Bitcoin. This has sparked discussions within the $XRP community about potential currency reserves that could lead to price increases.

The events of 2025, including court rulings and ETF plans, shape the future of $XRP, raising positive expectations in the community.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

OBBBA Law Restores R&D Deductions for Biotech Companies

chest

The One Big Beautiful Bill Act restores 100% deduction of R&D expenses for biotech companies, aimed at revitalizing domestic industries and reducing financial pressure.

user avatarZainab Kamara

Launch of OTCfi Token on Olympus Chain

chest

Launch of OTCfi Token on Olympus Chain as part of the partnership between Metavesco and BLAQclouds, aimed at expanding utility in crypto and OTC markets.

user avatarAisha Farooq

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.